相似文献
1
Bone marrow myeloid cells in regulation of multiple myeloma progression.
Cancer Immunol Immunother. 2017 Aug;66(8):1007-1014. doi: 10.1007/s00262-017-1992-0. Epub 2017 Apr 4.
2
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.
Cancer Lett. 2016 Feb 1;371(1):117-24. doi: 10.1016/j.canlet.2015.10.040. Epub 2015 Nov 27.
3
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
Oncotarget. 2015 Dec 22;6(41):43992-4004. doi: 10.18632/oncotarget.6083.
4
Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.
J Leukoc Biol. 2017 Aug;102(2):265-275. doi: 10.1189/jlb.3MR1116-468R. Epub 2017 Mar 2.
5
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
JCI Insight. 2019 Apr 23;5(11):127807. doi: 10.1172/jci.insight.127807.
6
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.
Int J Mol Sci. 2018 Nov 7;19(11):3503. doi: 10.3390/ijms19113503.
7
Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
Cancer Res. 2020 Mar 1;80(5):1036-1048. doi: 10.1158/0008-5472.CAN-19-0284. Epub 2020 Jan 7.
8
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.
Nat Immunol. 2024 May;25(5):820-833. doi: 10.1038/s41590-024-01808-x. Epub 2024 Apr 10.
9
CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
J Immunol. 2011 Aug 1;187(3):1243-53. doi: 10.4049/jimmunol.1100016. Epub 2011 Jun 29.
10
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
J Mol Med (Berl). 2016 Jan;94(1):21-35. doi: 10.1007/s00109-015-1345-4. Epub 2015 Oct 1.
引用本文的文献
1
Calprotectin as new potential clinical marker for multiple myeloma.
PLoS One. 2023 Mar 16;18(3):e0282841. doi: 10.1371/journal.pone.0282841. eCollection 2023.
2
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
JCI Insight. 2021 Feb 22;6(4):141683. doi: 10.1172/jci.insight.141683.
3
Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy.
Int J Mol Sci. 2020 Jan 30;21(3):904. doi: 10.3390/ijms21030904.
4
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.
Int J Mol Sci. 2018 Nov 7;19(11):3503. doi: 10.3390/ijms19113503.
5
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma.
Int J Nephrol. 2018 Sep 5;2018:4654717. doi: 10.1155/2018/4654717. eCollection 2018.
6
Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response.
Front Med (Lausanne). 2017 Jun 27;4:92. doi: 10.3389/fmed.2017.00092. eCollection 2017.
本文引用的文献
1
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.
Sci Immunol. 2016 Aug;1(2). doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.
2
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps.
Sci Transl Med. 2016 Oct 19;8(361):361ra138. doi: 10.1126/scitranslmed.aag1711.
3
Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma.
Blood. 2016 Nov 3;128(18):2241-2252. doi: 10.1182/blood-2016-01-695395. Epub 2016 Sep 13.
4
Priming of neutrophils toward NETosis promotes tumor growth.
Oncoimmunology. 2016 Feb 18;5(5):e1134073. doi: 10.1080/2162402X.2015.1134073. eCollection 2016 May.
5
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.
Nat Commun. 2016 Jul 6;7:12150. doi: 10.1038/ncomms12150.
6
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Oncotarget. 2016 Jun 21;7(25):37931-37943. doi: 10.18632/oncotarget.9270.
7
Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.
J Pathol. 2016 Jul;239(3):262-73. doi: 10.1002/path.4723. Epub 2016 Apr 29.
8
RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines.
Tumour Biol. 2016 Jul;37(7):9099-110. doi: 10.1007/s13277-015-4761-8. Epub 2016 Jan 14.
9
Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.
Cancer Res. 2016 Mar 15;76(6):1367-80. doi: 10.1158/0008-5472.CAN-15-1591. Epub 2016 Jan 12.
10
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy.
Cancer Lett. 2016 Feb 1;371(1):117-24. doi: 10.1016/j.canlet.2015.10.040. Epub 2015 Nov 27.
Zotero 插件